MedTrace Logo

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants

NCT03660436 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2018-12-19

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of experimental medication BMS-986165 in healthy male participants.

Conditions

  • Healthy Participants

Interventions

DRUG

BMS-986165

Specified dose on specified days

DRUG

MMF

Specified dose on specified days

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-14
Primary Completion
2018-10-10
Completion
2018-10-18
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03660436 on ClinicalTrials.gov